Under the gun after Opdivo setbacks, Bristol-Myers Squibb names a new chief scientist
Hot on the heels of a series of painful setbacks for its marquee program for Opdivo, Bristol-Myers Squibb $BMY is bringing in a new chief …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
